Rick Leigh Purdy - 06 Dec 2021 Form 4 Insider Report for CEN BIOTECH INC

Reporting relationship: SVP of Deals and Acquisitions, Director
Issuer ticker: N/A
Reported as of: 06 Dec 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Apr 2022, 17:00:22 UTC
Source filing: View source filing
Reporting owner signature: /s/ Rick Purdy

Key filing fact

Rick Leigh Purdy filed Form 4 for CEN BIOTECH INC on 13 Apr 2022.

Key facts

This page summarizes Rick Leigh Purdy's Form 4 filing for CEN BIOTECH INC.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 13 Apr 2022, 17:00.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CENBF transaction

Common Stock

Award

Transaction value: $0
Shares: +2,500,000
Change %: +808%
Price: $0.000000
Shares after: 2,809,470
Date: 06 Dec 2021
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

2,500,000 shares of common stock of the issuer were granted to Rick Purdy (the "Reporting Person") on December 6, 2021, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors. 700,000 shares vested as of December 6, 2021, and the remainder vest in accordance with the agreement.

Footnote F2

The Reporting Persons holds 309,470 shares of the Issuer's common stock in the name of Herc Holdings Inc.